Drug
Glucuronyl glucosamine glycan sulfate clinical trials
Also written Sulodexide, KRX-101 and vessel due f.
- studies test it
- 17
- open now
- 3
- in phase 3
- 9
- first study started
- 2005
Keep track of what changes. Save the glucuronyl glucosamine glycan sulfate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2007 | 2 |
| 2009 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 9
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 12
Keryx Biopharmaceuticals (3) · Centro Medico del Noroeste (1) · Clinedem (1) · St Joseph University, Beirut, Lebanon (1) · Ajou University School of Medicine (1) · Xijing Hospital (1) · Arianna Anticoagulazione Foundation (1) · Value Outcomes Ltd. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses glucuronyl glucosamine glycan sulfate is read from its arms, and is right about nine times in ten.
Testing it · 17
- Sulodexide in Controlling the Recurrence of PsoriasisEnrolling by invitationPhase 3Xijing HospitalNCT06982196Written as Sulodexide
- Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)RecruitingPhase 3Arianna Anticoagulazione FoundationNCT04257487Written as Sulodexide
- Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower ExtremitiesRecruitingPhase 3Value Outcomes Ltd.NCT05005052Written as Vessel
- Endothelial Protection in Convalescent COVID-19 PatientsTerminatedPhase 4Pirogov Russian National Research Medical UniversityNCT05252923Written as Sulodexide
- Endothelial Protection in Post COVID-19 Patients With SulodexideCompletedPhase 3Centro Medico del NoroesteNCT05371925Written as Sulodexide
- The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With SclerotherapyStatus unknownNot applicableChengdu University of Traditional Chinese MedicineNCT05654233Written as Sulodexide
- Effect of Sulodexide in Overt Diabetic NephropathyTerminatedPhase 4Keryx BiopharmaceuticalsNCT00130312Written as Sulodexide
- Suloexide in the Treatment of Early Stages of COVID-19CompletedPhase 2/3ClinedemNCT04483830Written as Sulodexide
- Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT AloneStatus unknownPhase 3Alfa Wassermann TunisiaNCT03370705Written as Sulodexide
- Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)WithdrawnPhase 4Steno Diabetes Center CopenhagenNCT03504566Written as Sulodexide
- Effect of Sulodexide in Early Diabetic NephropathyCompletedPhase 3Keryx BiopharmaceuticalsNCT00130208Written as Sulodexide
- Sulodexide Efficacy in Chronic Idiopathic Subjective TinnitusCompletedPhase 2St Joseph University, Beirut, LebanonNCT02737670Written as Sulodexide
- Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and SulodexideTerminatedPhase 4Bama GeVe, S.L.U.NCT02512601Written as Sulodexide
- Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong KongTerminatedPhase 3Keryx BiopharmaceuticalsNCT00462202Written as sulodexide
- Sulodexide Treatment in Patients With Dense Deposit DiseaseWithdrawnPhase 1University of IowaNCT00583427Written as Sulodexide
- Diabetic Retinopathy Sulodexide StudyCompletedPhase 2Ajou University School of MedicineNCT01295775Written as sulodexide
- The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney DiseaseStatus unknownPhase 3Corbridge Group Philippines, Inc.NCT01000545Written as Sulodexide
Codes
What other systems call glucuronyl glucosamine glycan sulfate · ClinicalTrials.gg INT002410
- MeSH (NLM) C007858glucuronyl glucosamine glycan sulfateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 75HGV0062CSULODEXIDEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C007858 | glucuronyl glucosamine glycan sulfate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 75HGV0062C | SULODEXIDE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.